Sivakumar Vijayaraghavalu

1.4k total citations
38 papers, 1.1k citations indexed

About

Sivakumar Vijayaraghavalu is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Sivakumar Vijayaraghavalu has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Biomaterials and 5 papers in Oncology. Recurrent topics in Sivakumar Vijayaraghavalu's work include Nanoparticle-Based Drug Delivery (7 papers), Epigenetics and DNA Methylation (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Sivakumar Vijayaraghavalu is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Epigenetics and DNA Methylation (4 papers) and Lipid Membrane Structure and Behavior (4 papers). Sivakumar Vijayaraghavalu collaborates with scholars based in United States, India and Saudi Arabia. Sivakumar Vijayaraghavalu's co-authors include Vinod Labhasetwar, Chiranjeevi Peetla, Sanjeeb Kumar Sahoo, Sanja Dimitrijevic, Tapan Kumar Jain, Jaspreet K. Vasir, Amulya K. Panda, Edgar E. Kooijman, Andrew Stine and Venugopalan Cheriyath and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Sivakumar Vijayaraghavalu

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sivakumar Vijayaraghavalu United States 15 542 309 241 194 129 38 1.1k
Raffaele Allevi Italy 20 415 0.8× 323 1.0× 221 0.9× 283 1.5× 76 0.6× 35 1.1k
Zhen Zhao China 19 502 0.9× 239 0.8× 154 0.6× 206 1.1× 103 0.8× 38 1.0k
Funan Liu China 20 613 1.1× 265 0.9× 302 1.3× 170 0.9× 158 1.2× 54 1.3k
Xiaohan Zhou China 22 638 1.2× 187 0.6× 290 1.2× 146 0.8× 214 1.7× 59 1.2k
Dawn Waterhouse Canada 20 704 1.3× 360 1.2× 308 1.3× 568 2.9× 121 0.9× 36 1.4k
Zhi Sheng United States 23 779 1.4× 193 0.6× 153 0.6× 63 0.3× 156 1.2× 58 1.4k
Calvin R. Justus United States 9 530 1.0× 169 0.5× 211 0.9× 88 0.5× 206 1.6× 10 1.0k
Stéphane Marchal France 21 681 1.3× 475 1.5× 365 1.5× 207 1.1× 138 1.1× 57 1.6k

Countries citing papers authored by Sivakumar Vijayaraghavalu

Since Specialization
Citations

This map shows the geographic impact of Sivakumar Vijayaraghavalu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivakumar Vijayaraghavalu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivakumar Vijayaraghavalu more than expected).

Fields of papers citing papers by Sivakumar Vijayaraghavalu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivakumar Vijayaraghavalu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivakumar Vijayaraghavalu. The network helps show where Sivakumar Vijayaraghavalu may publish in the future.

Co-authorship network of co-authors of Sivakumar Vijayaraghavalu

This figure shows the co-authorship network connecting the top 25 collaborators of Sivakumar Vijayaraghavalu. A scholar is included among the top collaborators of Sivakumar Vijayaraghavalu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivakumar Vijayaraghavalu. Sivakumar Vijayaraghavalu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Munish, et al.. (2025). Nanomedicine: Pioneering Advances in Neural Disease, Stroke and Spinal Cord Injury Treatment. SHILAP Revista de lepidopterología. 6(1). 9–9. 4 indexed citations
2.
Vijayaraghavalu, Sivakumar, et al.. (2025). Nanomedicine-Based Advances in Brain Cancer Treatment—A Review. SHILAP Revista de lepidopterología. 6(3). 28–28. 2 indexed citations
3.
Krishnaswami, Venkateshwaran, et al.. (2024). Functional biomaterials for corneal tissue regeneration. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Kumar, Munish, et al.. (2024). Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics. Cells. 13(10). 855–855. 7 indexed citations
5.
Vijayaraghavalu, Sivakumar, et al.. (2023). Synthesis, and control release properties of Zirconium –AA7075 - beta naphtha oxy acetate nanocomposites. Materials Today Proceedings.
6.
Mishra, Anurag, et al.. (2023). Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders. Cells. 12(8). 1159–1159. 8 indexed citations
7.
Perumal, Venkatesan, Arun Reddy Ravula, Ponnurengam Malliappan Sivakumar, et al.. (2023). Enhanced Targeted Delivery of Minocycline via Transferrin Conjugated Albumin Nanoparticle Improves Neuroprotection in a Blast Traumatic Brain Injury Model. Brain Sciences. 13(3). 402–402. 14 indexed citations
8.
Mishra, Anurag, et al.. (2022). Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy. Cancers. 14(21). 5268–5268. 26 indexed citations
9.
Ravichandran, Rajan, et al.. (2022). An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients. Scientific Reports. 12(1). 6413–6413. 25 indexed citations
10.
Vijayaraghavalu, Sivakumar, et al.. (2022). Microbiome and the inflammatory pathway in peri-implant health and disease with an updated review on treatment strategies. Journal of Oral Biology and Craniofacial Research. 13(2). 84–91. 12 indexed citations
11.
Vijayaraghavalu, Sivakumar, et al.. (2022). Clinical response of carboplatin-based chemotherapy and its association to genetic polymorphism in lung cancer patients from North India – A clinical pharmacogenomics study. Journal of Cancer Research and Therapeutics. 18(1). 109–118. 2 indexed citations
12.
Vijayaraghavalu, Sivakumar, et al.. (2021). Use of indomethacin in covid-19 patients — experience from two medical centres. 119(7). 42–46. 2 indexed citations
13.
Proulx, Jessica, Sivakumar Vijayaraghavalu, S. Manju, et al.. (2020). <p>Arginine-Modified Polymers Facilitate Poly (Lactide-Co-Glycolide)-Based Nanoparticle Gene Delivery to Primary Human Astrocytes</p>. International Journal of Nanomedicine. Volume 15. 3639–3647. 16 indexed citations
14.
Perumal, Venkatesan, Ponnurengam Malliappan Sivakumar, Ali Zarrabi, et al.. (2019). Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis. Journal of Photochemistry and Photobiology B Biology. 199. 111630–111630. 38 indexed citations
15.
Gao, Yue, et al.. (2019). Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury. Journal of Controlled Release. 302. 160–168. 32 indexed citations
16.
Raghavan, Vijay, Sivakumar Vijayaraghavalu, Yue Gao, et al.. (2018). Reaching for the Stars in the Brain: Polymer-Mediated Gene Delivery to Human Astrocytes. Molecular Therapy — Nucleic Acids. 12. 645–657. 12 indexed citations
17.
Kim, Min‐Sik, et al.. (2017). Pro-NP™ protect against TiO2 nanoparticle-induced phototoxicity in zebrafish model: exploring potential application for skin care. Drug Delivery and Translational Research. 7(3). 372–382. 8 indexed citations
19.
Vijayaraghavalu, Sivakumar & Vinod Labhasetwar. (2013). Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion. Cancer Letters. 331(1). 122–129. 36 indexed citations
20.
Vijayaraghavalu, Sivakumar, Chiranjeevi Peetla, Shan Lu, & Vinod Labhasetwar. (2012). Epigenetic Modulation of the Biophysical Properties of Drug-Resistant Cell Lipids to Restore Drug Transport and Endocytic Functions. Molecular Pharmaceutics. 9(9). 2730–2742. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026